Many of today's CEOs have been "shellshocked by crisis," making them extremely cautious and conservative, writes Monitor co-founder Joseph Fuller in Newsweek. “Companies will cast off their conservatism only when they accept that the standards they used to assess opportunities and evaluate risk in the past are no longer appropriate,” Fuller writes, adding that “the marketplace will ultimately reward those who stare down their fear and act.”

In a panel discussion organized by the Journal of Applied Corporate Finance, Monitor co-founder Joseph Fuller and other experts talk about ways that pharmaceutical companies can change their business models, financing structures, corporate governance models and incentive systems to build sustainable, profitable futures.